E. Ignatova

A constitutive interferon-high immunophenotype defines response to immunotherapy in colorectal cancer

Amelia Acha‐Sagredo, Pietro Andrei, Kalum Clayton et al. · Cancer Cell · 2025 · 38 citations · Full text

Cancer Immunosurveillance, Medicine, Immunology +7

Genome-Wide Methylotyping Resolves Breast Cancer Epigenetic Heterogeneity and Suggests Novel Therapeutic Perspectives

Alexey I. Kalinkin, E. Ignatova, Ekaterina Kuznetsova et al. · Epigenomics · 2019 · 33 citations · Full text

Microsatellite instability as a unique characteristic of tumors and a predictor of response to immune therapy

A. Tryakin, M. Yu. Fedyanin, Yu. A. Shelygin et al. · Malignant tumours · 2020 · 19 citations · Full text

Immunogenetics, Genome Instability, Somatic Variant +15

Genotyping of BRCA1, BRCA2, and CHEK2 germline mutations in Russian breast cancer patients using diagnostic biochips

Marina Emelyanova, E. Ignatova, T. P. Kazubskaya et al. · Molecular Biology · 2014 · 12 citations

Pharmacokinetics and safety of BCD-022, trastuzumab biosimilar candidate, compared to Herceptin in patients.

E. Ignatova, Olga Burdaeva, Marina P. Nechaeva et al. · Journal of Clinical Oncology · 2014 · 11 citations

Single Bcd-022, Therapeutic Drug Monitoring, Translational Medicine +14